Amy E. Tapper - 08 Nov 2022 Form 4 Insider Report for Imago BioSciences, Inc.

Role
Chief, Technical Operations
Signature
/s/ Hugh Y. Rienhoff, Jr., M.D., as Attorney-in-Fact for Amy E. Tapper
Issuer symbol
N/A
Transactions as of
08 Nov 2022
Net transactions value
$0
Form type
4
Filing time
14 Nov 2022, 17:57:23 UTC
Previous filing
04 Nov 2022
Next filing
20 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMGO Stock Option (Right to Buy) Award $0 +103,000 $0.000000 103,000 08 Nov 2022 Common Stock 103,000 $15.45 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from November 8, 2022 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.

Remarks:

Chief, Technical Operations